Author

Lori Capone

Observed names: Capone, Lori, L Capone, L. Capone

Observed institution: Celgene (United States)

OpenAlex ID: A5015956946

Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis

2009 · PH Schafer, A Parton, et al. · British Journal of Pharmacology · 426

PDF

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

2014 · P.H. Schafer, A. Parton, et al. · Cellular Signalling · 315

PDF

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

2010 · A. K. Gandhi, J. Kang, et al. · Current Cancer Drug Targets · 176

Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration

2012 · Matthew Hoffmann, Claudia Kasserra, et al. · Cancer Chemotherapy and Pharmacology · 125

PDF

Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study

2019 · Peter H. Schafer, Alan J. Kivitz, et al. · Rheumatology and Therapy · 71

PDF

Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity

2012 · Alexander L. Ruchelman, Hon-Wah Man, et al. · Bioorganic & Medicinal Chemistry Letters · 61

Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity

2017 · Yumi Nakayama, Jolanta Kosek, et al. · The Journal of Immunology · 55

PDF

Disposition, metabolism and mass balance of [ 14 C]apremilast following oral administration

2011 · Matthew Hoffmann, Gondi Kumar, et al. · Xenobiotica · 52

PDF

CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.

2012 · Anita K Gandhi, Derek Mendy, et al. · Blood · 8

Opposing Effects of Dexamethasone on Lenalidomide Activity in Multiple Myeloma: Additive/Synergistic Effects on Anti-Proliferative Activity on Myeloma Cells and Antagonistic Effects on Immune Function

2008 · Peter H Schafer, Anita K Gandhi, et al. · Blood · 6

Anti-Proliferative and Apoptotic Activity of Lenalidomide in Combination with Rituximab in Follicular Lymphoma: An in Vitro and Ex Vivo Analysis in Follicular Lymphoma Cells.

2009 · Anita K Gandhi, Jian Kang, et al. · Blood · 3

Targeting Cereblon with the High Affinity Immunomodulatory Compound CC-220: A Novel Therapeutic Agent for B Cell Dyscrasias

2012 · Peter H Schafer, Emily Rychak, et al. · Blood · 2

SAT0028 Aiolos overexpression in systemic lupus erythematosus b-cell subtypes and baff induced memory b-cell differentiation are reduced by cc-220 modulation of cereblon activity

2017 · GE Ringheim, J Kosek, et al. · Annals of the Rheumatic Diseases · 1

PDF

SAT0035 Inhibition of protein kinase c theta by the selective inhibitor cc-90005 induces t cell anergy

2017 · EM Hur, L Capone, et al. · Annals of the Rheumatic Diseases

PDF

Inhibition of B Cell Differentiation to the Plasmablast and Plasma Cell Lineage by CC-220, a Potent Modulator of the CRBN E3 Ubiquitin Ligase Complex

2012 · Peter H Schafer, Lori Capone, et al. · Blood

B444 Opposing Effects of Dexamethasone on Lenalidomide Activity in Multiple Myeloma

2009 · PH Schafer, AK Gandhi, et al. · Clinical Lymphoma & Myeloma

Antiproliferative Effects of Lenalidomide in Combination with Chemotherapeutic Agents in Lymphoma Cell Lines

2008 · Anita K Gandhi, Jian Kang, et al. · Blood

Works count: 18

Citation count: 1,301

H-index: 8

I10-index: 8